Abstract:Abstract(-)-Epigallocatechin-3-gallate (EGCG) is a well-known chemoprevention factor. Recent studies have revealed that EGCG triggers cancer cells undergoing apoptosis through p53-dependent pathway. How EGCG activates p53-dependent apoptosis is not fully understood. In the present study using JB6 cell as a model system, we have shown that EGCG can negatively regulate protein serine/threonine phosphatase-2A (PP-2A) to positively regulate p53-dependent apoptosis. First, EGCG at physiologic levels down-regulates PP-2A at the protein and enzyme activity levels. Second, EGCG induces apoptosis of JB6 cells, which is associated with hyperphosphorylation of p53 and up-regulation of the proapoptotic gene, Bak. DNA sequence analysis, gel mobility shifting, chromatin immunoprecipitation, and reporter gene activity assays revealed that p53 directly controls Bak in JB6 cells. Knockdown of p53 and Bak expression with RNAi substantially inhibits EGCG-induced apoptosis. Third, PP-2A directly interacts with p53 and dephosphorylates p53 at Ser-15 in vitro and in vivo. Fourth, overexpression of the catalytic subunit for PP-2A down-regulates p53 phosphorylation at Ser15, attenuates expression of the downstream proapoptotic gene, Bak, and antagonizes EGCG-induced apoptosis. Inhibition of PP-2A activity enhances p53 phosphorylation at Ser-15 and up-regulates Bak expression to promote EGCG-induced apoptosis. Finally, in the p53−/− H1299 and p53+/+ H1080 cells, EGCG down-regulates PP-2A similarly but induces differential apoptosis. In summary, our results show that (a) PP-2A directly dephosphorylates p53 at Ser-15; (b) P53 directly controls Bak expression; and (c) EGCG negatively regulates PP-2A. Together, our results show that EGCG-mediated negative regulation of PP-2A is an important molecular event for the activation of p53-dependent apoptosis during its chemoprevention. [Cancer Res 2008;68(11):4150–62]

G-Protein-Coupled Receptor Kinase 5 Phosphorylates P53 and Inhibits Dna Damage-Induced Apoptosis

Protein Phosphatase-2A is a Target of Epigallocatechin-3-Gallate and Modulates P53-Bak Apoptotic Pathway

Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10Amyc Cells Via Induction of Protein Kinase Cϵ

Abstract LB-75: Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10A Myc Cells Via Induction of Protein Kinase C Epsilon

The Role of GRK5 in Mitosis

DNA-dependent Protein Kinase-independent Activation of p53 in Response to DNA Damage

Data from the G Protein–Coupled Receptor 87 is Necessary for P53-Dependent Cell Survival in Response to Genotoxic Stress

Protein Phosphatase 5 and the Tumor Suppressor P53 Down-Regulate Each Other's Activities in Mice

P53 and Its Downstream Proteins As Molecular Targets of Cancer

Mitogen-Activated Protein Kinase Phosphatase 2: A Novel Transcription Target of P53 in Apoptosis

Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence.

The Phosphatase Mkp1 Is A Transcriptional Target Of P53 Involved In Cell Cycle Regulation

The Catalytic Subunit of DNA-dependent Protein Kinase Selectively Regulates P53-Dependent Apoptosis but Not Cell-Cycle Arrest.

PDCD5 Interacts with P53 and Functions As a Positive Regulator in the P53 Pathway.

The P53 Protein Is A Novel Substrate Of Ribosomal S6 Kinase 2 And A Critical Intermediary For Ribosomal S6 Kinase 2 And Histone H3 Interaction

P 53-Dependent Inhibition of FKHRL 1 in Response to DNA Damage Through Protein Kinase SGK 1

Protein Phosphatase 1 Inhibits P53 Signaling by Dephosphorylating and Stabilizing Mdmx

KRAB-type Zinc-Finger Protein Apak Specifically Regulates P53-Dependent Apoptosis

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

G-protein-coupled receptor kinase-5 promotes glioblastoma progression by targeting the nuclear factor kappa B pathway.

Integrated High Throughput Analysis Identifies GSK3 As a Crucial Determinant of P53-Mediated Apoptosis in Lung Cancer Cells